UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Plasma metabolome analysis of patients with major depressive disorder

Psychiatry and clinical neurosciences, 2018-05, Vol.72 (5), p.349-361

2018

Volltextzugriff (PDF)

Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis

Journal of leukocyte biology, 2007-12, Vol.82 (6), p.1382-1389

2007

Volltextzugriff (PDF)

Targeting Peripheral CB1 Receptors Reduces Ethanol Intake via a Gut-Brain Axis

Cell metabolism, 2019-06, Vol.29 (6), p.1320-1333.e8

2019

Volltextzugriff (PDF)

PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid ω-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease

PPAR Research, 2009-01, Vol.2009, p.952734-952734

2009

Volltextzugriff (PDF)

Association of a Novel Point Mutation (C159G) of the CTLA4 Gene With Type 1 Diabetes in West Africans but not in Chinese

Diabetes (New York, N.Y.), 2001-09, Vol.50 (9), p.2169-2171

2001

Volltextzugriff (PDF)

PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid -Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease

PPAR research, 2009, Vol.2009, p.1-20

2009

Volltextzugriff (PDF)

Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?

Trends in pharmacological sciences (Regular ed.), 2009-01, Vol.30 (1), p.1-7

2009

Volltextzugriff (PDF)

Endocannabinoid system in cancer cachexia

Current opinion in clinical nutrition and metabolic care, 2007-07, Vol.10 (4), p.443-448

Osei-Hyiaman, Douglas

2007

Volltextzugriff (PDF)

Biologically active, high levels of interleukin-22 inhibit hepatic gluconeogenesis but do not affect obesity and its metabolic consequences

Cell & bioscience, 2015-05, Vol.5 (1), p.25-25, Article 25

2015

Volltextzugriff (PDF)

Endocannabinoids and Liver Disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis

American journal of physiology: Gastrointestinal and liver physiology, 2008, Vol.57 (5)

2008

Volltextzugriff (PDF)

SUN-LB081 LXR Agonist 25-Hydroxycholesterol Modulates Plasma, Adrenal, and Hypothalamic Phosphoethanolamine Levels: Neuroendocrine Implications for HPA-Axis in Major Depressive Disorder

Journal of the Endocrine Society, 2019-04, Vol.3 (Supplement_1)

2019

Volltextzugriff (PDF)

SUN-LB082 Sexual Dimorphism of Phosphoethanolamine in HPA-Axis Response to LXR Agonist 25-Hydroxycholesterol: Neuroendocrine Implications for Major Depressive Disorder

Journal of the Endocrine Society, 2019-04, Vol.3 (Supplement_1)

2019

Volltextzugriff (PDF)

Dietary Linoleic Acid Elevates Endogenous Endocannabinoids (2‐AG and Anandamide) and Induces Obesity

The FASEB journal, 2013-04, Vol.27 (S1)

2013

Volltextzugriff (PDF)

Risk Factors for Breast Cancer among Japanese Women: A Case-Control Study in Ibaraki, Japan

Breast cancer (Tokyo, Japan), 1998-10, Vol.5 (4), p.351-358

1998

Volltextzugriff (PDF)

Should peripheral CB 1 cannabinoid receptors be selectively targeted for therapeutic gain?

Trends in pharmacological sciences (Regular ed.), 2009, Vol.30 (1), p.1-7

2009

Volltextzugriff (PDF)

Opinion: Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?

Trends in pharmacological sciences (Regular ed.), 2009-01, Vol.30 (1), p.1-7

2009

Volltextzugriff (PDF)

Transcriptional Regulation of Cannabinoid Receptor-1 Expression in the Liver by Retinoic Acid Acting via Retinoic Acid Receptor-g

The Journal of biological chemistry, 2010-06, Vol.285 (25), p.19002-19011

2010

Volltextzugriff (PDF)

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

The Journal of clinical investigation, 2010-10, Vol.120 (10), p.3735-3735

2010

Volltextzugriff (PDF)

Endocannabinoid activation at hepatic CB^sub 1^ receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

The Journal of clinical investigation, 2005-05, Vol.115 (5), p.1298

2005

Volltextzugriff (PDF)

Hepatic CB^sub 1^ receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

The Journal of clinical investigation, 2008-09, Vol.118 (9), p.3160

2008

Volltextzugriff (PDF)

Cell type-dependent pro- and anti-inflammatory role of STAT3 in alcoholic liver injury

Gastroenterology (New York, N.Y. 1943), 2008-01, Vol.134 (4), p.1148-1158

2008

Volltextzugriff (PDF)

Paracrine Activation of Hepatic CB 1 Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver

Cell metabolism, 2008, Vol.7 (3), p.227-235

2008

Volltextzugriff (PDF)

The Role of Endocannabinoids and Their Receptors in the Control of Hepatic Functions

The Liver, 2009, p.1091-1103

2009

Volltextzugriff (PDF)

The role of the endocannabinoid system in liver ischemia reperfusion injury

The FASEB journal, 2007, Vol.21 (6), p.A807-A807

2007

Volltextzugriff (PDF)

Endocannabinoid activation at hepatic CB sub(1) receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

The Journal of clinical investigation, 2005-05, Vol.115 (5), p.1298-1305

2005

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

ThemaRisk Factors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(28)
Buchkapitel
(1)

Sprache

Englisch
(29)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Fatty Acids
(4)
Obesity
(4)
Biological And Medical Sciences
(3)
Endocrinology & Metabolism
(3)
Insulin Resistance
(3)
Liver
(3)
Africans
(2)
Biomedical Research
(2)
Body Fat
(2)
Cell Biology
(2)
Chinese
(2)
Enzymes
(2)
Fundamental And Applied Biological Sciences. Psychology
(2)
Gene Mutations
(2)
Genetic Aspects
(2)
Humans
(2)
Insulin
(2)
Medical Sciences
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Plasma metabolome analysis of patients with major depressive disorder

Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis

Targeting Peripheral CB1 Receptors Reduces Ethanol Intake via a Gut-Brain Axis

PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid ω-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease

Association of a Novel Point Mutation (C159G) of the CTLA4 Gene With Type 1 Diabetes in West Africans but not in Chinese

PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid -Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease

Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?

Endocannabinoid system in cancer cachexia

Biologically active, high levels of interleukin-22 inhibit hepatic gluconeogenesis but do not affect obesity and its metabolic consequences

Endocannabinoids and Liver Disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis

SUN-LB081 LXR Agonist 25-Hydroxycholesterol Modulates Plasma, Adrenal, and Hypothalamic Phosphoethanolamine Levels: Neuroendocrine Implications for HPA-Axis in Major Depressive Disorder

SUN-LB082 Sexual Dimorphism of Phosphoethanolamine in HPA-Axis Response to LXR Agonist 25-Hydroxycholesterol: Neuroendocrine Implications for Major Depressive Disorder

Dietary Linoleic Acid Elevates Endogenous Endocannabinoids (2‐AG and Anandamide) and Induces Obesity

Risk Factors for Breast Cancer among Japanese Women: A Case-Control Study in Ibaraki, Japan

Should peripheral CB 1 cannabinoid receptors be selectively targeted for therapeutic gain?

Opinion: Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?

Transcriptional Regulation of Cannabinoid Receptor-1 Expression in the Liver by Retinoic Acid Acting via Retinoic Acid Receptor-g

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

Endocannabinoid activation at hepatic CB^sub 1^ receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

Hepatic CB^sub 1^ receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

Cell type-dependent pro- and anti-inflammatory role of STAT3 in alcoholic liver injury

Paracrine Activation of Hepatic CB 1 Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver

The Role of Endocannabinoids and Their Receptors in the Control of Hepatic Functions

The role of the endocannabinoid system in liver ischemia reperfusion injury

Endocannabinoid activation at hepatic CB sub(1) receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

Aktive Filter

Suchergebnisse filtern